Business ❯Healthcare
Pharmaceutical Industry Investments Stock Market Pharmaceuticals Pharmaceuticals Corporate Finance Market Trends Corporate Governance Rare Diseases Drug Development
The initiative is being rolled out with broad commissioner discretion over voucher awards, raising questions about oversight of its fast-track approvals.
